KUOW | May 27, 2026
Nathan Sackett, MD, MS joins KUOW to talk about ketamine, a substance that is showing up more and more in popular culture.
KUOW | May 27, 2026
Nathan Sackett, MD, MS joins KUOW to talk about ketamine, a substance that is showing up more and more in popular culture.
UW Magazine | May 12, 2026
Frank Chopp, who served as representative for Seattle’s 43rd Legislative District from 1995 to 2019, sponsored the bill that brought CBHL to life.
Right as Rain | April 27, 2026
“Men often rely on their spouse as their primary source of emotional support,” says Jürgen Unützer, MD, MPH. “After divorce, they may have fewer close confidants compared to women, who often have broader social networks.”
UW Medicine Newsroom | April 30, 2026
In this Q&A, Kristen Lindgren, PhD, ABPP explains what triggers stress, it's health effects, and how to cope.
Department News | April 30, 2026
In May, Mollie Forrester, LICSW, will highlight our department’s leadership in adult psychiatry access when she presents on the Psychiatry Consultation Line (PCL) at the American Psychiatric Association annual meeting in San Francisco.
UW Medicine Newsroom | April 29, 2026
“Chopp’s longstanding support for mental health treatment has helped many more patients and their families get the help they need,” said Jürgen Unützer, MD, MPH.
CBC | March 31, 2026
Screen time can help combat loneliness, which is common among older adults, especially those with mobility challenges, says Patrick Raue, PhD.
Department News | March 30, 2026
The Garvey Institute Center for Neuromodulation reached an important milestone in March when, for the first time, they cared for 100 patients with state-of-the-art neuromodulation treatments such as ECT and TMS in a single week.
Department News | March 30, 2026
Earlier this month, PBSCI Chair Jürgen Unützer, MD, MPH, MA hosted a kickoff meeting for the department’s new AI Advisory Council.
UW Medicine Newsroom | March 30, 2026
“It’s interesting that we could find no other research papers where clinicians in the United States are asked about treating cannabis-related adverse conditions," said Beatriz Carlini, PhD, MPH.